Cambridge, MA · Founded 2023 · Privately Held (backing)
Developer of a neural interface technology designed to enhance the integration of bioelectronics with the human body. NeuroBionics is based in Cambridge, MA and was founded in 2023. It was valued at $33.3 million at its seed round in Dec 2025, the last priced event on record. It has raised $9.3 million across 1 recorded round; the latest was a $4.2 million seed round in Nov 2025.
PMV mark · valuation
$33.3M
Oct 2026
Priced at
its seed round
Dec 2025
Total raised
$9.3M
Last round
Seed Round
Nov 2025
Team — not yet on record
No current team members for NeuroBionics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of NeuroBionics with a free account
·The complete investor list: 19 names
·Watch NeuroBionics: the Monday email on marks, rounds and moves
